Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Related structures:
AlphaFold database: Q4Q5H9
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 10 |
GO:0016462 | pyrophosphatase activity | 5 | 10 |
GO:0016787 | hydrolase activity | 2 | 10 |
GO:0016817 | hydrolase activity, acting on acid anhydrides | 3 | 10 |
GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 4 | 10 |
GO:0047429 | nucleoside triphosphate diphosphatase activity | 6 | 10 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 15 | 17 | PF00675 | 0.280 |
CLV_PCSK_KEX2_1 | 14 | 16 | PF00082 | 0.281 |
CLV_PCSK_KEX2_1 | 177 | 179 | PF00082 | 0.314 |
CLV_PCSK_KEX2_1 | 77 | 79 | PF00082 | 0.291 |
CLV_PCSK_PC1ET2_1 | 177 | 179 | PF00082 | 0.301 |
CLV_PCSK_PC1ET2_1 | 77 | 79 | PF00082 | 0.291 |
CLV_PCSK_SKI1_1 | 200 | 204 | PF00082 | 0.314 |
CLV_PCSK_SKI1_1 | 74 | 78 | PF00082 | 0.260 |
DEG_APCC_DBOX_1 | 199 | 207 | PF00400 | 0.514 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.530 |
DOC_MAPK_gen_1 | 177 | 183 | PF00069 | 0.514 |
DOC_MAPK_gen_1 | 74 | 84 | PF00069 | 0.381 |
DOC_MAPK_MEF2A_6 | 57 | 65 | PF00069 | 0.381 |
DOC_MAPK_MEF2A_6 | 77 | 86 | PF00069 | 0.498 |
DOC_WW_Pin1_4 | 30 | 35 | PF00397 | 0.493 |
LIG_Actin_WH2_2 | 149 | 166 | PF00022 | 0.441 |
LIG_AP2alpha_2 | 45 | 47 | PF02296 | 0.450 |
LIG_BRCT_BRCA1_1 | 43 | 47 | PF00533 | 0.491 |
LIG_FHA_1 | 121 | 127 | PF00498 | 0.450 |
LIG_FHA_1 | 24 | 30 | PF00498 | 0.500 |
LIG_FHA_1 | 48 | 54 | PF00498 | 0.437 |
LIG_FHA_2 | 185 | 191 | PF00498 | 0.514 |
LIG_LIR_Apic_2 | 28 | 34 | PF02991 | 0.514 |
LIG_LIR_Gen_1 | 26 | 34 | PF02991 | 0.436 |
LIG_LIR_Gen_1 | 85 | 92 | PF02991 | 0.432 |
LIG_LIR_Nem_3 | 143 | 148 | PF02991 | 0.478 |
LIG_LIR_Nem_3 | 26 | 30 | PF02991 | 0.419 |
LIG_LIR_Nem_3 | 85 | 89 | PF02991 | 0.432 |
LIG_NRP_CendR_1 | 220 | 221 | PF00754 | 0.468 |
LIG_SH2_CRK | 27 | 31 | PF00017 | 0.514 |
LIG_SH2_GRB2like | 113 | 116 | PF00017 | 0.467 |
LIG_SH2_NCK_1 | 27 | 31 | PF00017 | 0.514 |
LIG_SH2_STAP1 | 27 | 31 | PF00017 | 0.514 |
LIG_SH2_STAT5 | 31 | 34 | PF00017 | 0.516 |
LIG_SH3_3 | 132 | 138 | PF00018 | 0.461 |
LIG_SH3_3 | 203 | 209 | PF00018 | 0.475 |
LIG_TRAF2_1 | 187 | 190 | PF00917 | 0.519 |
LIG_TYR_ITSM | 141 | 148 | PF00017 | 0.514 |
MOD_CK2_1 | 184 | 190 | PF00069 | 0.521 |
MOD_Cter_Amidation | 218 | 221 | PF01082 | 0.463 |
MOD_GlcNHglycan | 10 | 13 | PF01048 | 0.252 |
MOD_GSK3_1 | 117 | 124 | PF00069 | 0.477 |
MOD_GSK3_1 | 133 | 140 | PF00069 | 0.447 |
MOD_GSK3_1 | 210 | 217 | PF00069 | 0.454 |
MOD_GSK3_1 | 41 | 48 | PF00069 | 0.488 |
MOD_GSK3_1 | 78 | 85 | PF00069 | 0.512 |
MOD_N-GLC_1 | 138 | 143 | PF02516 | 0.286 |
MOD_NEK2_1 | 47 | 52 | PF00069 | 0.474 |
MOD_NEK2_2 | 195 | 200 | PF00069 | 0.501 |
MOD_PK_1 | 78 | 84 | PF00069 | 0.501 |
MOD_PKA_2 | 41 | 47 | PF00069 | 0.511 |
MOD_Plk_1 | 138 | 144 | PF00069 | 0.504 |
MOD_Plk_1 | 149 | 155 | PF00069 | 0.524 |
MOD_Plk_1 | 195 | 201 | PF00069 | 0.521 |
MOD_Plk_2-3 | 184 | 190 | PF00069 | 0.501 |
MOD_Plk_4 | 117 | 123 | PF00069 | 0.480 |
MOD_Plk_4 | 140 | 146 | PF00069 | 0.450 |
MOD_ProDKin_1 | 30 | 36 | PF00069 | 0.493 |
MOD_SUMO_rev_2 | 175 | 183 | PF00179 | 0.493 |
MOD_SUMO_rev_2 | 33 | 41 | PF00179 | 0.452 |
TRG_ENDOCYTIC_2 | 145 | 148 | PF00928 | 0.514 |
TRG_ENDOCYTIC_2 | 27 | 30 | PF00928 | 0.475 |
TRG_ER_diArg_1 | 13 | 16 | PF00400 | 0.520 |
TRG_Pf-PMV_PEXEL_1 | 16 | 20 | PF00026 | 0.293 |
TRG_Pf-PMV_PEXEL_1 | 200 | 204 | PF00026 | 0.323 |
TRG_Pf-PMV_PEXEL_1 | 51 | 55 | PF00026 | 0.359 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PGQ1 | Leptomonas seymouri | 67% | 100% |
A0A0S4KKD9 | Bodo saltans | 28% | 80% |
A0A1X0NW04 | Trypanosomatidae | 37% | 100% |
A0A3Q8IGW3 | Leishmania donovani | 92% | 100% |
A0A3R7M9P1 | Trypanosoma rangeli | 38% | 100% |
A4HK85 | Leishmania braziliensis | 85% | 100% |
A4I7S0 | Leishmania infantum | 92% | 100% |
B0B7R8 | Chlamydia trachomatis serovar L2 (strain 434/Bu / ATCC VR-902B) | 28% | 100% |
B0BBY3 | Chlamydia trachomatis serovar L2b (strain UCH-1/proctitis) | 28% | 100% |
B2J6P8 | Nostoc punctiforme (strain ATCC 29133 / PCC 73102) | 26% | 100% |
D0A9X9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 43% | 100% |
E9B2M8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |
O84353 | Chlamydia trachomatis (strain D/UW-3/Cx) | 28% | 100% |
P58632 | Nostoc sp. (strain PCC 7120 / SAG 25.82 / UTEX 2576) | 24% | 100% |
Q253S7 | Chlamydia felis (strain Fe/C-56) | 26% | 100% |
Q3KM09 | Chlamydia trachomatis serovar A (strain ATCC VR-571B / DSM 19440 / HAR-13) | 28% | 100% |
Q46BZ6 | Methanosarcina barkeri (strain Fusaro / DSM 804) | 27% | 100% |
Q54TC5 | Dictyostelium discoideum | 35% | 100% |
Q823U1 | Chlamydia caviae (strain ATCC VR-813 / DSM 19441 / 03DC25 / GPIC) | 25% | 100% |
Q9PK45 | Chlamydia muridarum (strain MoPn / Nigg) | 28% | 100% |
Q9RV24 | Deinococcus radiodurans (strain ATCC 13939 / DSM 20539 / JCM 16871 / LMG 4051 / NBRC 15346 / NCIMB 9279 / R1 / VKM B-1422) | 29% | 100% |